- •Preface
- •Contributors
- •Contents
- •Introduction
- •Literature Review
- •Major Issues
- •Major Studies
- •Negative Studies
- •References
- •1.1.1 Introduction
- •1.1.3 Torsional Ultrasound
- •1.1.4 Our Procedure for Emulsifying the Nucleus
- •References
- •1.2 Transitioning to Bimanual MICS
- •1.2.1 Introduction
- •1.2.2 Technique
- •1.2.3 Summary
- •1.3 0.7 mm Microincision Cataract Surgery
- •1.3.1 Sub 1 mm MICS: Why?
- •1.3.3 Instrumentation
- •1.3.3.2 0.7 mm Irrigating Instruments
- •1.3.4 Surgery
- •1.3.4.1 Incision
- •1.3.4.2 Capsulorhexis
- •1.3.4.3 Hydrodissection
- •1.3.4.4 Prechopping
- •1.3.5 0.7 mm MICS Combined Procedures
- •1.3.5.1 0.7 mm MICS and Glaucoma Surgery
- •1.3.6 Summary
- •References
- •2. MICS Instrumentation
- •2.1 MICS Instrument Choice: The First Step in the Transition
- •2.2 MICS Incision
- •2.3 MICS Capsulorhexis
- •2.4 MICS Prechopping
- •2.5 MICS Irrigation/Aspiration Instruments
- •2.5.1 19 G Instruments
- •2.5.2 21 G Instruments
- •2.6 MICS Auxiliary Instrument
- •2.6.1 Scissors
- •2.6.2 Gas Forced Infusion
- •2.6.3 Surge Prevention
- •2.7 New MICS Instruments
- •2.7.1 Flat Instruments
- •References
- •3.1 Introduction
- •3.2 Power Generation
- •3.3.1 Tuning
- •3.2.2 Phaco Energy
- •3.2.2.1 Low Frequency Energy
- •3.2.2.2 High Frequency Energy
- •3.2.3 Transient Cavitation
- •3.2.4 Sustained Cavitation
- •3.3.1 Alteration of Stroke Length
- •3.3.2 Alteration of Duration
- •3.3.2.1 Burst Mode
- •3.3.2.2 Pulse Mode
- •Micro Pulse (Hyper-Pulse)
- •Pulse Shaping
- •3.3.3 Alteration of Emission
- •3.4 Fluidics
- •3.5 Vacuum Sources
- •3.6 Surge
- •3.7.1 Micro-incisional Phaco
- •3.7.2 Bimanual Micro-Incisional Phaco
- •3.7.3 Micro-Incisional Coaxial Phaco
- •3.7.3.1 Irrigation and Aspiration
- •3.8 Conclusion
- •Reference
- •Further Reading
- •4.1 Introduction
- •4.3 Incision Size
- •4.4 Torsional Ultrasound
- •4.5 Conclusion
- •References
- •5. Technology Available
- •5.1 How to Better Use Fluidics with MICS
- •5.1.1 Physical Considerations
- •5.1.1.2 Chamber Stability
- •5.1.1.3 Holdability
- •5.1.2 Surgical Considerations
- •5.1.2.2 Phaco Technique
- •5.1.2.4 The OS3 and CataRhex SwissTech Platforms
- •Equipment
- •Machine Settings
- •5.2 How to Use Power Modulation in MICS
- •5.2.1 Introduction
- •5.2.3 The Concept of Unoccluded Flow Vacuum
- •5.2.4 The Intricacies of Ultrasound Power Modulation
- •5.2.5 The Variable Incidence of Wound Burn Rates
- •References
- •5.3 MICS with Different Platforms
- •5.3.1 MICS with the Accurus Surgical System
- •5.3.1.1 Introduction and Historic Background
- •5.3.1.3 Surgical Parameters for MICS with Accurus
- •5.3.1.4 Final Considerations
- •5.3.2.1 Introduction
- •5.3.2.7 Technology for MICS on the AMO Signature
- •5.3.2.8 Applying Signature Technology to CMICS and BMICS
- •5.3.3 MICS with Different Platforms: Stellaris Vision Enhancement System
- •5.3.3.2 Evaluating the Stellaris Vision Enhancement System
- •5.3.3.3 The Advantages of BMICS
- •References
- •6.1 Pupil Dilation and Preoperative Preparation
- •6.1.1 Managing the Small Pupil
- •6.1.2 Techniques that Depend on the Manipulation of the Pupil
- •6.1.3 Iris Surgery
- •6.1.4 Preoperative Preparation and Infection Prophylaxis
- •6.1.5 Evaluating Risk
- •6.1.6 Assessing Your Approach
- •6.1.7 Preventing Infection, Step by Step
- •6.1.8 Sample Protocol Outline
- •6.1.9 A Careful, Critical Eye
- •References
- •6.2 Incisions
- •References
- •6.3 Thermodynamics
- •6.3.1 Introduction
- •6.3.2 Corneal Thermal Damage
- •6.3.3 Heat Generation
- •6.3.4 Factors that Contribute to Thermal Incision Damage
- •6.3.4.1 Energy Emission: Amount and Pattern of How the Energy Is Delivered
- •6.3.4.3 Viscoelastic Devices and Possible Occlusion of the Aspiration Line
- •6.3.4.4 Irrigation Flow
- •6.3.4.5 Position of the Tip Inside the Incision
- •6.3.4.6 Tip Design
- •6.3.4.7 Surgical Technique
- •6.3.5 Conclusion
- •6.4 Using Ophthalmic Viscosurgical Devices with Smaller Incisions
- •6.4.1 Introduction
- •6.4.1.1 The Nature of OVDs: Rheology
- •6.4.1.3 Soft Shell and Ultimate Soft Shell Technique (SST & USST)
- •6.4.2 Routine, Special and complicated Cases
- •6.4.2.1 Phakic and Anterior Chamber IOLs
- •6.4.2.3 Fuchs’ Endothelial Dystrophy
- •6.4.2.5 Capsular Staining for White & Black Cataracts
- •6.4.2.6 Flomax® Intraoperative Floppy Iris Syndrome USST
- •6.4.3 Discussion
- •References
- •6.5 Capsulorhexis
- •References
- •References
- •6.7 Biaxial Microincision Cataract Surgery: Techniques and Sample Surgical Parameters
- •6.8.1 Surgical Technique
- •6.8.2 Advantages
- •6.8.3 Disadvantages
- •6.8.4 Final Thoughts
- •References
- •6.9 BiMICS vs. CoMICS: Our Actual Technique (Bimanual Micro Cataract Surgery vs. Coaxial Micro Cataract Surgery)
- •6.9.1 Introduction
- •6.9.2 Historical Background
- •6.9.3 BiMICS. BiManual MicroIncision Cataract Surgery
- •6.9.3.1 Introduction
- •6.9.3.2 Instrumentation
- •6.9.3.5 Phacotips
- •6.9.3.6 Capsulorhexis
- •6.9.3.7 Phaco Knives
- •6.9.3.8 The Phaco Machines
- •6.9.3.9 Phaco Pumps
- •6.9.3.10 Ultrasound Power Delivery
- •6.9.3.11 IOL Implantation
- •6.9.3.12 Astigmatism
- •6.9.4.1 Capsulorhexis
- •6.9.4.2 Phacotips
- •6.9.4.3 The Phaco Machines
- •6.9.4.4 Phaco Pumps
- •6.9.4.5 Ultrasound Power Delivery
- •6.9.4.6 Irrigation-Aspiration
- •6.9.4.7 Incision-Assisted IOL Implantation
- •6.9.5 Conclusion
- •References
- •6.10 Endophthalmitis Prevention
- •6.10.1 Antibiotic Prophylaxis
- •6.10.2 Wound Construction
- •6.10.3 Summary
- •References
- •7.1 High Myopia
- •7.2 Posterior Polar Cataract
- •7.3 Posterior Subluxed Cataracts
- •7.4 Mature Cataract with Zonular Dialysis
- •7.5 Punctured Posterior Capsule
- •7.6 Posterior Capsule Rupture
- •7.7 Pseudoexfoliation
- •7.8 Rock-Hard Nuclei
- •7.9 Switching Hands
- •7.10 Microcornea or Microphthalmos
- •7.11 Large Iridodialysis and Zonular Defects
- •7.12 Intraoperative Floppy Iris Syndrome (IFIS)
- •7.14 Iris Bombé
- •7.15 Very Shallow Anterior Chambers
- •7.16 Refractive Lens Exchange
- •7.18 Intraocular Cautery
- •7.19 Biaxial Microincision Instruments
- •References
- •7.1 MICS in Special Cases: Incomplete Capsulorhexis
- •7.1.1 Introduction
- •7.1.2 Avoiding Complications While Constructing Your Microcapsulorhexis
- •7.1.3 Avoiding Complications During Biaxial Phaco with an Incomplete Capsulorhexis
- •7.1.4 Avoiding Complications During IOL Insertion with an Incomplete Capsulorhexis
- •7.1.5 Conclusions
- •References
- •7.2 MICS in Special Cases (on CD): Vitreous Loss
- •7.2.1 Introduction
- •7.2.2 Posterior Capsule Tears and Vitreous Prolapse
- •7.2.3 Vitreous and the Epinucleus or Cortex
- •7.2.4 Different Techniques Other than Pars Plana Vitrectomy for Nuclear Loss in Vitreous
- •7.2.5 Pars Plana Vitrectomy
- •7.2.6 Zonulolysis
- •References
- •7.3 How to Deal with Very Hard and Intumescent Cataracts
- •7.3.1 Introduction
- •7.3.2 Types of Cataracts
- •7.3.3 Management of Hard Cataracts Through Biaxial Technique
- •7.3.4 Incision
- •7.3.5 Capsulorrhexis
- •7.3.6 Hydrodissection
- •7.3.8 Conclusion
- •References
- •8. IOL Types and Implantation Techniques
- •8.1 MICS Intraocular Lenses
- •8.1.1 Introduction
- •8.1.2 Lenses
- •8.1.2.2 ThinOptX MICS IOLs (ThinOptX, Abingdon, VA)
- •8.1.2.3 Akreos MI60 AO Micro Incision IOL (Bausch & Lomb, Rochester, NY)
- •8.1.2.4 IOLtech MICS lens (IOLtech, La Rochelle, France; and Carl Zeiss Meditec, Stuttgard, Germany)
- •8.1.3 Optical Quality of MICS IOLs
- •8.1.4 Conclusion
- •References
- •8.2 Implantation Techniques
- •8.2.2 Prerequisites to a Sub-2 Injection
- •8.2.3 IOLs Used for Injection Through Microincision
- •8.2.3.1 Material
- •8.2.3.2 Design
- •8.2.3.3 Optic Design
- •8.2.3.4 Haptic Design
- •8.2.3.5 Posterior Barrier (360°)
- •8.2.4 Injectors Meant for Microincision
- •8.2.4.1 Objectives of Injectors Meant for Microincision
- •8.2.4.2 Characteristics of Sub-2 Injectors
- •8.2.4.3 The Cartridges
- •Loading Chambers
- •Injection Tunnels and Cartridge Tips
- •8.2.4.4 The Plunger Tips (or plunger)
- •8.2.4.5 Pushing Systems
- •8.2.4.6 Injector Bodies
- •8.2.4.7 Principal Sub-2 Injectors
- •8.2.5 Visco Elastic Substances and Injection Through Microincision
- •8.2.6 Techniques of Sub-2 Injection
- •8.2.6.2 Incision Construction
- •8.2.6.3 Pressurization of the Anterior Chamber
- •8.2.6.4 Loading the Cartridge
- •8.2.6.5 Loading the Injector
- •8.2.6.6 Insertion of the Plunger Tip
- •8.2.6.7 Injection in the Anterior Chamber
- •8.2.6.8 Positioning the IOL in the Capsular Bag
- •8.2.6.9 Removing the VES
- •8.2.6.10 Thin Roller Injector
- •8.2.6.11 Conclusion
- •Reference
- •8.3 Special Lenses
- •8.3.1 Toric Posterior Chamber Intraocular Lenses in Cataract Surgery and Refractive Lens Exchange
- •8.3.1.1 Introduction
- •8.3.1.3 T-IOL Calculation
- •8.3.1.4 Current T-IOL Models
- •8.3.1.5 Preoperative Marking
- •8.3.1.6 Clinical Indications
- •8.3.1.7 Custom-Made Lenses
- •8.3.1.8 Conclusion for Practice
- •References
- •8.3.2 Special Lenses: MF
- •8.3.2.1 Discussion
- •8.3.2.2 Conclusion
- •8.3.2.3 Outlook
- •References
- •8.3.3 Special Lenses: Aspheric
- •References
- •8.3.4 Intraocular Lenses to Restore and Preserve Vision Following Cataract Surgery
- •8.3.4.1 Introduction
- •8.3.4.2 Why Filter Blue Light?
- •Summary
- •8.3.4.3 Importance of Blue Light to Cataract and Refractive Lens Exchange Patients
- •Summary
- •8.3.4.4 Quality of Vision with Blue Light Filtering IOLs
- •Summary
- •8.3.4.5 Clinical Experience
- •Summary
- •8.3.4.6 Unresolved Issues and Future Considerations
- •References
- •8.3.5 Microincision Intraocular Lenses: Others
- •8.3.5.1 ThinOptX®
- •8.3.5.2 Smart IOL
- •8.3.5.4 AcriTec
- •8.3.5.5 Akreos
- •8.3.5.7 Rayner
- •8.3.5.8 Injectable Polymers
- •8.3.5.9 Final Comments
- •References
- •9. Outcomes
- •9.1 Safety: MICS versus Coaxial Phaco
- •9.1.1 Introduction
- •9.1.2 Visual Outcomes
- •9.1.3 Incision Damage
- •9.1.4 Corneal Incision Burn
- •9.1.5 Corneal Changes
- •9.1.6 Infection
- •9.1.7 Summary
- •References
- •9.2 Control of Corneal Astigmatism and Aberrations
- •9.2.1 Introduction: Impacts of MICS Incision on the Outcomes of Cataract Surgery
- •9.2.2 Objective Evaluation of Corneal Incision
- •9.2.3 Control of Corneal Aberration and Astigmatism with MICS
- •9.2.4 Role of Corneal Aberrometry in Evaluating MICS Incision
- •9.2.5 Role of OCT in Evaluating MICS Incision
- •9.2.6 Our Experience in Corneal Aberrations and Astigmatism After MICS
- •9.2.7 Conclusion
- •References
- •9.3 Corneal Endothelium and Other Safety Issues
- •9.4 Incision Quality in MICS
- •9.4.1 Introduction: History of Incision Size Reduction
- •9.4.2 The Trends Towards Microincision Cataract Surgery (BMICS)
- •9.4.3 Advantages of Minimizing the Incision Size
- •9.4.4 Model for the Analysis of Corneal Incision Quality [21]
- •9.4.5 Our Protocol for Evaluation of Incision Quality in BMICS [21]
- •9.4.6 Results
- •9.4.6.1 Visual, Refractive and Biomicroscopic Outcomes
- •9.4.6.2 Incision Imaging (OCT) Outcomes
- •9.4.8 Conclusion
- •References
- •INDEX
304 |
B. El Kady and J. L. Alió |
Fig. 9.4.34 OCT images of MICS incisions showing an example of endothelial bulge (a) and endothelial bullae (b) (white arrows)
a
b
evaluation of the incision, these group of eyes with BMICS have been compared with an equal number of eyes (25) having the same grade of cataract deepening on the Lens Opacities Classification System III [23]. The second group of patients underwent surgery using the other method currently available for microincision lens surgery using a protected (sleeved) tip, which is the microcoaxial phacoemulsification with an incision of 2.2 mm (microphaco) [24–26].
9.4.6 Results
9.4.6.1Visual, Refractive and Biomicroscopic Outcomes
Only UCVA (uncorrected visual acuity) at 1 week and 1 month postoperatively were statistically significant. However, BSCVA (best spectacle corrected visual
acuity), postoperative sphere and cylinder showed no statistical difference (Fig. 9.4.35, Table 9.4.1).
MICS showed less corneal edema at the first postoperative day by slit-lamp biomicroscopy (Table 9.4.1).
9.4.6.2 Incision Imaging (OCT) Outcomes
Three different OCT incision parameters were evaluated: pachymetric (corneal thickness) values, qualitative (non numerical) incision data and quantitative (numerical) incision data. When comparing both groups, we observed the following results:
Pachemetry measurements (Fig. 9.4.36): BMICS showed less corneal thickness in an area of 5–7 mm of the cornea but only on day-1 (659.92 ± 56.74 vs. 697.00 ± 80.56 μm; p = 0.066).
Qualitative (descriptive) incision data are summarized in (Table 9.4.2) from which we had the following observations: No misalignment of epithelial edge were
9.4 Incision Quality in MICS |
|
|
|
305 |
|
0,8 |
|
|
0,9 |
|
|
|
P=0.09 |
|
0,85 |
|
|
0,6 |
|
|
|
||
|
|
|
|
||
|
|
|
0,8 |
|
|
0,4 |
|
P=0.06 |
|
|
|
|
|
|
|
||
|
|
|
0,75 |
|
|
0,2 |
|
|
|
|
|
|
|
|
0,7 |
|
|
|
MICS |
Microphaco |
MICS |
Microphaco |
|
0 |
|
|
|||
|
|
0,65 |
|
||
Day 1 |
Week 1 |
Month 1 |
|
||
Week 1 |
Month 1 |
||||
|
UCVA |
|
|||
|
|
BSCVA |
|
Fig. 9.4.35 Evolution of UCVA and BSCVA, MICS vs. microphaco, throughout the follow-up visits
Table 9.4.1 Comparison
of visual acuities, refraction, slit-lamp examination and IOP between both study groups, day 1, week 1 and month 1 postoperatively.
Parameter |
MICS |
Microphaco |
p value |
UCDVA (mean ± SD) |
|
|
|
Day 1 |
0.29 ± 0.20 |
0.33 ± 0.19 |
0.58 |
Week 1 |
0.51 ± 0.26 |
0.64 ± 0.27 |
0.09 |
Month 1 |
0.54 ± 0.23 |
0.71 ± 0.27 |
0.06 |
BSCDVA (mean ± SD)
Week 1 |
0.74 ± 0.26 |
0.8 ± 0.19 |
0.42 |
Month 1 |
0.78 ± 0.27 |
0.86 ± 0.20 |
0.32 |
Sphere D (mean ± SD) |
|
|
|
Week 1 |
0.11 ± 0.90 |
−0.02 ± 0.81 |
0.60 |
Month 1 |
0.16 ± 0.97 |
0.15 ± 0.96 |
0.90 |
Cylinder D (mean ± SD) |
|
|
|
Week 1 |
−0.75 ± 0.53 |
−0.96 ± 1.11 |
0.40 |
Month 1 |
−0.61 ± 0.62 |
−0.65 ± 0.75 |
0.50 |
IOP (mmHg) (mean ± SD) |
|
|
|
Day 1 |
14.32 ± 4.4 |
16.41 ± 6.19 |
0.19 |
Week 1 |
13.88 ± 2.64 |
14.09 ± 3.72 |
0.82 |
Month 1 |
13.75 ± 2.77 |
14.38 ± 3.03 |
0.43 |
Flare (%) |
|
|
|
Day 1 |
56.00 |
30.4 |
0.09 |
Week 1 |
16.00 |
4.2 |
0.35 |
Month 1 |
0.00 |
0.00 |
– |
Edema (%) |
|
|
|
Day 1 |
44.00 |
87.00 |
0.003 |
Week 1 |
12.00 |
4.2 |
0.61 |
Month 1 |
0.00 |
0.00 |
– |
Seidel (%) |
|
|
|
Day 1 |
8.00 |
0.00 |
0.49 |
Week 1 |
0.00 |
0.00 |
– |
Month 1 |
0.00 |
0.00 |
– |
PCO (%) |
|
|
|
Day 1 |
4.00 |
8.7 |
0.60 |
Week 1 |
4.00 |
4.2 |
1.00 |
Month 1 |
4.00 |
0.00 |
1.00 |
306 |
B. El Kady and J. L. Alió |
Fig. 9.4.36 OCT measured central corneal thickness and mean thickness in an area of 2–5 and 5–7 mm of the cornea among study groups, day 1, week 1 and month 1 postoperatively (P value denotes the only significant difference)
|
|
|
|
P=0,066 |
|
|
|
|
MICS |
|
Microphaco |
|
|
|
800 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
600 |
|
|
|
|
|
|
|
|
|
|
|
|
um |
400 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
CCT |
CT |
2-5 |
CT 5-7 |
CCT |
CT |
2-5 |
CT |
5-7 |
CCT |
CT 2-5 |
CT |
5-7 |
Day 1 |
Week 1 |
Month 1 |
CCT
Table 9.4.2 OCT measured descriptive incision data among study groups, day 1, week 1 and month 1 postoperatively
Parameter |
Day 1 |
|
|
Week 1 |
|
|
Month 1 |
|
|
MICS (%) |
Microphaco |
p |
MICS (%) |
Microphaco |
p |
MICS (%) |
Microphaco p |
|
|
(%) |
|
|
(%) |
|
|
(%) |
Epithelial gaping |
0.00 |
0.00 |
|
0.00 |
0.00 |
|
0.00 |
0.00 |
Endothelial gaping |
64.00 |
72.00 |
0.76 |
76.00 |
72.7 |
1.00 |
0.00 |
0.00 |
DM detachment |
60.00 |
80.00 |
0.22 |
32.00 |
45.5 |
0.38 |
0.0 |
0.00 |
Endothelial bullae |
8.00 |
16.00 |
0.67 |
12.00 |
9.1 |
1.00 |
0.00 |
0.00 |
No coaptation |
3.12 ± 7.61a |
2.65 ± 5.48a |
0.46 |
1.10 ± 2.51a |
0.59 ± 1.22a |
0.82 |
0.00 |
0.00 |
aMean ± SD |
|
|
|
|
|
|
|
|
present, and at 1 month, there was no misalignment of either the epithelial or endothelial edges, or Descemet’s detachments (Fig. 9.4.37).
Quantitative incision data (incision angle and thickness) revealed that corneal thickness at 1 mm temporal to the incision was slightly less in microphaco only on day-1 (0.95 ± 0.14 vs. 0.88 ± 0.13 mm; p = 0.09), (Fig. 9.4.38). Angle of the incision trigonometrically calculated revealed excellent incision quality in both groups with no statistically significant differences (Table 9.4.3, Figs. 9.4.39 and 9.4.40).
9.4.6.3Topographic and Aberrometric
Outcomes
At 1 month postsurgery, corneal topography maps revealed that the postoperative corneal powers didn’t differ (44.12 ± 2.26 D vs. 43.96 ± 1.76 D; p = 0.90). Corneal asphericity differs significantly between BMICS and microphaco, with a more prolate topography in the BMICS group (Q 4.5 mm, −0.08 ± 0.39 vs. 0.2 ± 0.72; p = 0.05; Q 8 mm, −0.22 ± 0.45 vs. 0.05 ± 0.49; p = 0.04), (Fig. 9.4.41).
9.4 Incision Quality in MICS |
307 |
Fig. 9.4.37 OCT images showing evolution of the incision of a MICS case throughout the follow-up visits
Day 1
Week 1
Month 1
Fig. 9.4.38 OCT measured corneal thickness in the area of the incision and at 1 mm at each side of the incision throughout the follow-up visits
1.4 |
|
|
|
|
|
|
|
|
|
|
|
|
P=0,09 |
|
|
|
|
MICS |
|
Microphaco |
|
1.2 |
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
0.8 |
|
|
|
|
|
|
|
|
|
|
mm |
|
|
|
|
|
|
|
|
|
|
0.6 |
|
|
|
|
|
|
|
|
|
|
0.4 |
|
|
|
|
|
|
|
|
|
|
0.2 |
|
|
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
Inc.T |
Inc. T nasal |
Inc. T temporal |
Inc.T |
Inc. T nasal |
Inc. T |
temporal |
Inc.T |
Inc. T |
nasal |
Inc. T temporal |
|
Day 1 |
|
|
Week 1 |
|
|
|
Month 1 |
|
|
308 |
B. El Kady and J. L. Alió |
Table 9.4.3 OCT measured incision thickness, central and at 1 mm on either side of the incision and incision angle among study groups, day 1, week 1, and month 1 postoperatively
Fig. 9.4.39 OCT images showing angle of the incision MICS vs. microphaco (white arrows)
Parameter |
MICS |
Microphaco |
p value |
|
|
(mean ± SD) |
(mean ± SD) |
|
|
Central incision thickness (mm) |
|
|
|
|
Day 1 |
1.09 ± 0.17 |
1.09 |
± 0.16 |
0.82 |
Week 1 |
0.95 ± 0.17 |
1.02 |
± 0.21 |
0.16 |
Month 1 |
0.85 ± 0.08 |
0.86 |
± 0.1 |
0.95 |
Incision thickness 1 mm nasal (mm) |
|
|
|
|
Day 1 |
0.89 ± 0.12 |
0.93 |
± 0.12 |
0.27 |
Week 1 |
0.81 ± 0.07 |
0.82 |
± 0.11 |
0.65 |
Month 1 |
0.80 ± 0.08 |
0.76 |
± 0.07 |
0.11 |
Incision thickness 1 mm temporal (mm) |
|
|
|
|
Day 1 |
0.95 ± 0.14 |
0.88 |
± 0.13 |
0.09 |
Week 1 |
0.83 ± 0.09 |
0.84 |
± 0.08 |
0.67 |
Month 1 |
0.8 ± 0.11 |
0.78 |
± 0.09 |
0.41 |
Incision angle (degrees) |
|
|
|
|
Day 1 |
42.05 ± 13.23 |
39.25 ± 9.89 |
0.4 |
|
Week 1 |
61.81 ± 16.93 |
42.50 ± 16.67 |
– |
|
Month 1 |
46.49 ± 8.98 |
44.24 ± 10.57 |
0.37 |
|
MICS
Microphaco
9.4 Incision Quality in MICS |
309 |

MICS 
Microphaco
° 48 |
|
|
46 |
P=0,4 |
|
|
|
|
44 |
|
|
42 |
|
|
40 |
|
|
38 |
|
|
36 |
|
|
34 |
Day 1 |
Month 1 |
|
Fig. 9.4.40 Evolution of the angle of the incision MICS vs. microphaco throughout the follow-up visits
Corneal aberrations with the corresponding p values are shown (Fig. 9.4.42) denoting that RMS values for astigmatism and HOA were slightly better in BMICS, p = 0.06 and 0.05 respectively. Strehl ratio didn’t differ significantly between groups (0.12 ± 0.03 vs. 0.12 ± 0.05; p = 0.53).
No statistically significant differences between groups were observed in ocular aberrometry parameters: RMS total (1.97 ± 0.91 vs. 2.35 ± 1.12 μm; p = 0.2) and RMS higher-order aberrations (HOA) (0.64 ± 0.22 vs. 0.74 ± 0.1 μm; p = 0.1) with good optical quality in both groups (Fig. 9.4.43).
P=0,05 |
P=0,04 |
0.70

MICS 
Microphaco
0.50 |
|
2.50 |
0.30 |
(microns) |
2.00 |
0.10 |
1.50 |
|
|
||
-0.10 |
1.00 |
|
RMS |
|
|
-0.30 |
0.50 |
|
|
|
|
Q; 4.5mm |
Q; 8mm |
0.00 |
|
|
MICS 
Microphaco
Total |
HOA |
Fig. 9.4.41 Evolution of corneal asphericity MICS vs. micro- |
|
phaco throughout the follow-up visits |
Fig. 9.4.43 Ocular aberrations for both groups |
Fig. 9.4.42 Corneal aberrations at 6-mm pupil diameter for both groups with the corresponding p values
|
3.50 |
|
|
|
|
|
|
|
p=0,26 |
|
|
|
MICS |
Microphaco |
|
|
3.00 |
|
|
|
|
|
|
(microns) |
2.50 |
|
|
|
|
|
|
2.00 |
|
|
|
|
|
|
|
1.50 |
p=0,06 |
|
|
p=0,05 |
|
|
|
|
|
|
|
|
|
||
|
|
|
p=0,76 |
|
|
|
|
RMS |
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
p=0,93 |
|
|
p=0,53 |
||
|
0.50 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
0.00 |
|
|
|
|
|
|
|
-0.50 |
|
|
|
|
|
|
|
Total |
Astigmatism |
Spherical |
Coma |
HOA |
Strehl |
Ratio |
|
|
|
|
|
|||
310 |
B. El Kady and J. L. Alió |
Thin incision |
Thick incision |
MICS |
Microphaco |
Fig. 9.4.44 An example of a thin incision in a MICS case and a thick incision in a microphaco case, correlation between OCT pachymetric values and OCT imaging assessment
9.4.7Special Focus on the Role of OCT
in the Evaluation of Incision Quality in BMICS
We have to refer that our clinical observations about BMICS incision were subsequently confirmed objectively by OCT assessment parameters (Fig. 9.4.44), confirming the role of OCT as an accurate quantitative tool assessing the incision effect and quality [17].
The importance of OCT as a tool for evaluating tiny incisions results in the fact that it is a noncontact modality and therefore, introduces no artifacts and is more precise than slit-lamp evaluations, (Fig. 9.4.45) [17, 27, 28].
An important parameter of incision quality is the angle of the incision. Our study [21] shows that BMICS provides an incision angle previously described as
critical for self-sealability [29], to obtain secure ocular incisions unaffected by the level of IOP, especially among sutureless cataract incisions, which provide a perfectly coapted barrier against the invasion of pathogenic organisms, supported by the fact that we did not have any single case of endophthalmitis in our study [21]. Although variable and sometimes poor incision apposition with fluctuation with IOP has been reported by many authors [27, 29–31], our results were obtained using a large number of eyes, with longer follow-up, compared with others who used either postmortem human globes or animal eyes.
Interestingly, we may encounter a localized subclinical Descemet’s membrane detachment. This could be explained by double-cut incisions or by stretching the incisions during IOL insertion [17, 21, 32].
